Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
Crossref DOI link: https://doi.org/10.1038/bmt.2016.128
Published Online: 2016-05-23
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Christopeit, M
Badbaran, A
Zabelina, T
Zeck, G
Fehse, B
Ayuk, F
Wolschke, C
Kröger, N
Text and Data Mining valid from 2016-05-23
Version of Record valid from 2016-05-23
Article History
First Online: 23 May 2016
Competing interests
: The authors declare no conflict of interest.